Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra in Pulmonary Arterial Hypertension
NCT01479010Phase 2Terminated
- Sponsor
- Virginia Commonwealth University
- Start
- Nov 2011
- Primary completion
- Nov 2013
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of anakinra in pulmonary arterial hypertension (PAH), sponsored by Virginia Commonwealth University. Started Nov 2011; status: terminated.
02
Drugs
anakinra
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT01479010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01479010.